[The use of Ovestin to overcome the side effects of treatment with GnRH agonists (Zoladex)].

Akusherstvo i ginekologiia · 1998 · vol. 37(4) , pp. 25–6 · PMID:10360048 · W2412620766
article OA: closed CC0
View on OpenAlex View on PubMed

Abstract

The LHRH analogues are used very much in gynecological practice, mostly for a long treatment periods. The menopausal side effects occur often and causes the patients to withdraw from treatment. The GnRh analogues are used for the treatment of endometriosis, uterine fibroids, for breast cancer, and pre and post operatively as hormonal therapy for endometrial cancer. 12 patients were given combined vaginal Ovestin and GnRh analogues (Zoladex). Another 12 patients were taking GnRh analogues alone without Ovestin creme, and this group searched as a control group. The group with the Ovestin had less side effects than the control group. This difference was statistically significant about the cervicovaginal symptoms (p less than 0.01). The treatment with vaginal estrogenes can better and improve the tolerance to therapy with GnRh analogues.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents, Hormonal Estriol Gonadotropin-Releasing Hormone Goserelin Adolescent Adult Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Drug Therapy, Combination Estriol Female Genital Diseases, Female Genital Diseases, Female Gonadotropin-Releasing Hormone Goserelin Goserelin Humans Ointments Postoperative Care Preoperative Care

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-18T06:15:08.409253+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:29.640636+00:00
License: CC0 · commercial use OK